PriceTargets.com logo

Trupanion - TRUP Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $33.20
  • Forecasted Upside: 47.88%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$22.45 As of 04/19/2024 05:00 PM ET
▲ +1.09 (5.10%)

This chart shows the closing price for TRUP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Trupanion Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRUP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRUP

Analyst Price Target is $33.20
▲ +47.88% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Trupanion in the last 3 months. The average price target is $33.20, with a high forecast of $47.00 and a low forecast of $28.00. The average price target represents a 47.88% upside from the last price of $22.45.

This chart shows the closing price for TRUP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 polled investment analysts is to hold stock in Trupanion. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/5/2024Piper SandlerLower TargetNeutral ➝ Neutral$32.00 ➝ $28.00Low
2/20/2024Evercore ISILower TargetOutperform ➝ Outperform$35.00 ➝ $31.00Low
2/16/2024Piper SandlerLower TargetNeutral ➝ Neutral$33.00 ➝ $32.00Low
2/16/2024Stifel NicolausBoost TargetHold ➝ Hold$25.00 ➝ $28.00Low
12/18/2023Piper SandlerBoost TargetNeutral ➝ Neutral$28.00 ➝ $33.00Low
11/3/2023Piper SandlerLower TargetNeutral ➝ Neutral$32.00 ➝ $28.00Low
7/5/2023Evercore ISILower Target$45.00 ➝ $35.00Low
5/7/2023Bank of AmericaDowngradeBuy ➝ Neutral$72.00 ➝ $32.00Low
5/5/2023Lake Street CapitalLower Target$75.00 ➝ $47.00Low
5/5/2023Piper SandlerLower Target$44.00 ➝ $33.00Low
4/21/2023Stifel NicolausLower TargetHold$51.00 ➝ $37.00Low
4/5/2023Piper SandlerLower TargetNeutral$63.00 ➝ $44.00Low
3/28/2023Jefferies Financial GroupLower TargetBuy$75.00 ➝ $65.00Low
3/27/2023Bank of AmericaLower Target$109.00 ➝ $89.00Low
3/24/2023Evercore ISILower Target$68.00 ➝ $59.00Low
2/16/2023Piper SandlerBoost TargetNeutral$53.00 ➝ $63.00Low
2/16/2023Canaccord Genuity GroupBoost TargetBuy$66.00 ➝ $72.00Low
2/16/2023Lake Street CapitalBoost TargetBuy$67.00 ➝ $75.00Low
12/20/2022Piper SandlerBoost TargetNeutral$46.00 ➝ $53.00Low
11/4/2022Lake Street CapitalLower Target$67.00Low
11/4/2022UBS GroupLower TargetBuy ➝ Buy$80.00 ➝ $66.00Low
10/13/2022Piper SandlerLower Target$62.00Low
10/7/2022Piper SandlerLower TargetNeutral$69.00 ➝ $62.00Low
9/21/2022Jefferies Financial GroupInitiated CoverageBuy$77.00Low
8/9/2022Evercore ISILower Target$85.00Low
8/5/2022Canaccord Genuity GroupLower Target$100.00 ➝ $90.00Low
8/4/2022Northland SecuritiesLower Target$80.00 ➝ $70.00Low
8/4/2022Piper SandlerDowngradeOverweight ➝ Neutral$80.00 ➝ $69.00Low
5/27/2022Piper SandlerLower TargetOverweight$95.00 ➝ $80.00High
4/29/2022Canaccord Genuity GroupLower Target$140.00 ➝ $100.00High
4/29/2022Piper SandlerLower Target$150.00 ➝ $95.00High
4/20/2022Bank of AmericaLower TargetBuy$118.00 ➝ $110.00Medium
2/24/2022Bank of AmericaUpgradeNeutral ➝ Buy$129.00 ➝ $118.00High
2/17/2022Lake Street CapitalLower Target$150.00 ➝ $120.00Medium
2/17/2022Canaccord Genuity GroupLower Target$150.00 ➝ $140.00High
2/7/2022Piper SandlerLower Target$183.00 ➝ $156.00Medium
12/8/2021Piper SandlerBoost TargetOverweight ➝ Overweight$126.00 ➝ $183.00High
11/8/2021Bank of AmericaDowngradeBuy ➝ Neutral$112.00 ➝ $129.00Low
10/18/2021Bank of AmericaInitiated CoverageBuy$112.00Medium
10/6/2021Piper SandlerInitiated CoverageOverweight$110.00Medium
4/5/2021Evercore ISIInitiated CoverageOutperform$100.00High
2/11/2021Lake Street CapitalBoost TargetBuy$85.00 ➝ $150.00Low
10/30/2020Lake Street CapitalBoost Target$67.00 ➝ $85.00High
8/10/2020GuggenheimDowngradeBuy ➝ NeutralLow
8/5/2020Lake Street CapitalBoost TargetPositive ➝ Buy$50.00 ➝ $67.00High
8/5/2020Northland SecuritiesDowngradeOutperform ➝ Market Perform$42.00 ➝ $50.00High
7/30/2020Stifel NicolausBoost TargetHold$33.00 ➝ $43.00Low
6/25/2020Northland SecuritiesInitiated CoverageBuy$42.00Medium
6/15/2020Royal Bank of CanadaReiterated RatingBuy$40.00High
6/9/2020Northland SecuritiesInitiated CoverageBuy$42.00Low
5/1/2020Lake Street CapitalReiterated RatingBuy$50.00Low
5/1/2020Royal Bank of CanadaBoost TargetOutperform$39.00 ➝ $40.00High
5/1/2020Northland SecuritiesReiterated RatingBuy$35.00High
4/27/2020Royal Bank of CanadaReiterated RatingBuy$39.00High
4/8/2020Royal Bank of CanadaReiterated RatingBuy$39.00High
4/6/2020Northland SecuritiesReiterated RatingBuy$35.00High
2/14/2020Lake Street CapitalBoost TargetBuy$46.00 ➝ $50.00Low
2/14/2020Raymond JamesDowngradeOutperform ➝ Market PerformHigh
1/8/2020Stifel NicolausDowngradeBuy ➝ Hold$32.00 ➝ $38.00High
11/18/2019GuggenheimBoost TargetBuy$35.00 ➝ $36.00Low
11/6/2019Northland SecuritiesReiterated RatingBuy$40.00High
10/11/2019Craig HallumSet TargetHold$20.00Low
8/16/2019Craig HallumDowngradeBuy ➝ Hold$29.00High
7/31/2019Royal Bank of CanadaSet TargetBuy$38.00Low
7/31/2019Northland SecuritiesReiterated RatingBuy$40.00High
5/23/2019GuggenheimInitiated CoverageBuy ➝ Buy$35.00High
5/14/2019Northland SecuritiesInitiated CoverageBuy$40.00High
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 4 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 9 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 4 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 11 very positive mentions
  • 23 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Mentions as of
2/19/2024
  • 4 very positive mentions
  • 25 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 8 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 8 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Trupanion logo
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $22.45
Low: $21.36
High: $22.93

50 Day Range

MA: $26.62
Low: $21.36
High: $35.28

52 Week Range

Now: $22.45
Low: $18.45
High: $37.71

Volume

932,514 shs

Average Volume

682,567 shs

Market Capitalization

$938.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Trupanion?

The following Wall Street sell-side analysts have issued research reports on Trupanion in the last twelve months: Bank of America Co., Evercore ISI, Lake Street Capital, Piper Sandler, Stifel Nicolaus, and StockNews.com.
View the latest analyst ratings for TRUP.

What is the current price target for Trupanion?

5 Wall Street analysts have set twelve-month price targets for Trupanion in the last year. Their average twelve-month price target is $33.20, suggesting a possible upside of 47.9%. Lake Street Capital has the highest price target set, predicting TRUP will reach $47.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $28.00 for Trupanion in the next year.
View the latest price targets for TRUP.

What is the current consensus analyst rating for Trupanion?

Trupanion currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TRUP, but not buy more shares or sell existing shares.
View the latest ratings for TRUP.

What other companies compete with Trupanion?

Other companies that are similar to Trupanion include Oscar Health, German American Bancorp, Centerspace, Plymouth Industrial REIT and QCR. Learn More about companies similar to Trupanion.

How do I contact Trupanion's investor relations team?

Trupanion's physical mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider's listed phone number is (855) 727-9079 and its investor relations email address is [email protected]. The official website for Trupanion is www.trupanion.com. Learn More about contacing Trupanion investor relations.